ANIX
Price
$3.37
Change
-$0.01 (-0.30%)
Updated
Sep 26, 02:56 PM (EDT)
Capitalization
111.09M
Earnings call today
ZBIO
Price
$20.10
Change
+$1.48 (+7.95%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
784.09M
46 days until earnings call
Interact to see
Advertisement

ANIX vs ZBIO

Header iconANIX vs ZBIO Comparison
Open Charts ANIX vs ZBIOBanner chart's image
Anixa Biosciences
Price$3.37
Change-$0.01 (-0.30%)
Volume$100
Capitalization111.09M
Zenas Biopharma
Price$20.10
Change+$1.48 (+7.95%)
Volume$873
Capitalization784.09M
ANIX vs ZBIO Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. ZBIO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and ZBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ANIX: $3.38 vs. ZBIO: $18.62)
Brand notoriety: ANIX and ZBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 54% vs. ZBIO: 118%
Market capitalization -- ANIX: $111.09M vs. ZBIO: $784.09M
ANIX [@Biotechnology] is valued at $111.09M. ZBIO’s [@Biotechnology] market capitalization is $784.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileZBIO’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • ZBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ZBIO is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 6 TA indicator(s) are bullish while ZBIO’s TA Score has 3 bullish TA indicator(s).

  • ANIX’s TA Score: 6 bullish, 4 bearish.
  • ZBIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANIX is a better buy in the short-term than ZBIO.

Price Growth

ANIX (@Biotechnology) experienced а +0.15% price change this week, while ZBIO (@Biotechnology) price change was -4.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.18%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 26, 2025.

ZBIO is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZBIO($784M) has a higher market cap than ANIX($111M). ZBIO YTD gains are higher at: 127.350 vs. ANIX (45.474). ANIX has higher annual earnings (EBITDA): -13.11M vs. ZBIO (-189M). ZBIO has more cash in the bank: 273M vs. ANIX (15.6M). ANIX has less debt than ZBIO: ANIX (221K) vs ZBIO (1.01M). ZBIO has higher revenues than ANIX: ZBIO (15M) vs ANIX (0).
ANIXZBIOANIX / ZBIO
Capitalization111M784M14%
EBITDA-13.11M-189M7%
Gain YTD45.474127.35036%
P/E RatioN/AN/A-
Revenue015M-
Total Cash15.6M273M6%
Total Debt221K1.01M22%
FUNDAMENTALS RATINGS
ANIX vs ZBIO: Fundamental Ratings
ANIX
ZBIO
OUTLOOK RATING
1..100
1420
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4836
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5046

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZBIO's Valuation (41) in the null industry is in the same range as ANIX (71) in the Computer Peripherals industry. This means that ZBIO’s stock grew similarly to ANIX’s over the last 12 months.

ANIX's Profit vs Risk Rating (77) in the Computer Peripherals industry is in the same range as ZBIO (100) in the null industry. This means that ANIX’s stock grew similarly to ZBIO’s over the last 12 months.

ANIX's SMR Rating (98) in the Computer Peripherals industry is in the same range as ZBIO (100) in the null industry. This means that ANIX’s stock grew similarly to ZBIO’s over the last 12 months.

ZBIO's Price Growth Rating (36) in the null industry is in the same range as ANIX (48) in the Computer Peripherals industry. This means that ZBIO’s stock grew similarly to ANIX’s over the last 12 months.

ZBIO's P/E Growth Rating (100) in the null industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that ZBIO’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXZBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 3 days ago
90%
Declines
ODDS (%)
Bearish Trend 15 days ago
83%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BINP0.02N/A
+23.27%
Bionoid Pharma Inc.
JASUF0.03N/A
N/A
Jasmine International Public Co., Ltd.
SOMLF36.19N/A
N/A
Secom Co., Ltd.
GBNXF19.43-0.09
-0.46%
Gibson Energy, Inc.
OONEF0.35N/A
-0.88%
01 Quantum Inc.

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with GLUE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-1.89%
GLUE - ANIX
42%
Loosely correlated
-1.06%
LGND - ANIX
35%
Loosely correlated
-1.30%
VERA - ANIX
32%
Poorly correlated
+3.14%
KLTO - ANIX
32%
Poorly correlated
-5.58%
ZBIO - ANIX
32%
Poorly correlated
-8.19%
More

ZBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZBIO has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBIO jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZBIO
1D Price
Change %
ZBIO100%
-8.19%
CRNX - ZBIO
41%
Loosely correlated
+2.02%
RGNX - ZBIO
41%
Loosely correlated
-1.89%
NUVL - ZBIO
41%
Loosely correlated
-2.54%
PYXS - ZBIO
41%
Loosely correlated
-5.07%
ATXS - ZBIO
40%
Loosely correlated
-1.65%
More